Taylor Wessing advises leading-edge life sciences companies on transformational roll-up and $114m crossover financing


Taylor Wessing has advised Oppilan Pharma Limited and Zomagen Biosciences Limited on their roll-up and sale into Ventyx Biosciences, Inc. and concurrent $114m crossover financing led by venBio Partners. 

Ventyx, Oppilan and Zomagen were established as asset-centric companies with immunology compounds, each linked to founder, Raju Mohan, and backed by New Science Ventures. The transaction has brought together the three cutting-edge life sciences companies to create a clinical-stage biotechnology company advancing a pipeline of immune modulators to treat inflammatory diseases and autoimmune disorders. The combined venture has attracted a top tier international investor base, including Third Point, RTW Investments, Janus Henderson Investors, Wellington Management and Orbimed. 

To read more information, click here.

Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private

Taylor Wessing